11 Recruiting Studies Using Lazertinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Lazertinib
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
📍 City of Hope Duarte — Duarte, California
Advanced or Metastatic Non-small Cell Lung Cancer
View Study & Checklist ➔A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
📍 Clinical Research Facility — Duarte, California
Non-Small-Cell Lung Cancer
View Study & Checklist ➔Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
📍 Ironwood Cancer and Research Center — Chandler, Arizona
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Premedication to Reduce Amivantamab Associated Infusion Related Reactions
📍 Compassionate Cancer Care — Fountain Valley, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
📍 Arizona Oncology Associates, PC - HAL — Goodyear, Arizona
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
📍 Southern Cancer Center, PC — Mobile, Alabama
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
📍 Southern Cancer Center, PC — Daphne, Alabama
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
📍 City of Hope — Duarte, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
📍 University of California at San Diego — La Jolla, California
Carcinoma, Non-small-Cell Lung
View Study & Checklist ➔To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation
📍 Cancer Care of North Florida, PA (Lake City Cancer Care, LLC) - Medical Oncology — Lake City, Florida
Advanced Solid Tumors
View Study & Checklist ➔